Mehdi Hamadani on Administering Outpatient Lymphoma Therapy During the Pandemic

William A. Wood, MD, MPH, on the New ASH Research Collaborative Data Hub COVID-19 Registry for Hematologic Malignancy

William A. Wood, MD, MPH, of the University of North Carolina at Chapel Hill, and Oversight Group Chair for the new COVID-19 registry, talks about why it was formed, how it c...

Multiple Myeloma

COVID-19

The ASCO Post Staff

Saad Z. Usmani, MD: In My Experience Question 4

For patients with multiple myeloma who are currently on clinical trials, what are the most pressing issues as we fight COVID-19?

Recorded April 24, 2020.

Lymphoma

COVID-19

The ASCO Post Staff

Mehdi Hamadani, MD: In My Experience Question 2

During the COVID-19 pandemic, when and why would you consider delaying autologous transplant for patients with diffuse large B-cell lymphoma in second complete remission?

Hematologic Malignancies

COVID-19

The ASCO Post Staff

Miguel-Angel Perales, MD, and Syed A. Abutalib, MD, on Bone Marrow Transplants During the COVID-19 Pandemic

Syed A. Abutalib, MD, of Cancer Treatment Centers of America, talks with Miguel-Angel Perales, MD, of Memorial Sloan Kettering Cancer Center, about the chall...

Multiple Myeloma

COVID-19

The ASCO Post Staff

Irene M. Ghobrial, MD, on How COVID-19 is Changing the Conduct of Clinical Trials

Irene M. Ghobrial, MD, of Dana-Farber Cancer Institute, talks about PROMISE—her screening study for people at high-risk of developing precursor conditions of multiple myeloma...

Mehdi Hamadani, MD: In My Experience Question 1

Related Videos

William A. Wood, MD, MPH, on the New ASH Research Collaborative Data Hub COVID-19 Registry for Hematologic Malignancy

Saad Z. Usmani, MD: In My Experience Question 4

Mehdi Hamadani, MD: In My Experience Question 2

Miguel-Angel Perales, MD, and Syed A. Abutalib, MD, on Bone Marrow Transplants During the COVID-19 Pandemic

Irene M. Ghobrial, MD, on How COVID-19 is Changing the Conduct of Clinical Trials

Continuous Coverage of COVID-19

Adverse Events in Patients With Melanoma Treated With Ipilimumab Results of a Toxicity Monitoring Program

Outcomes With Ribociclib Across Intrinsic Subtypes of HR-Positive, HER2-Negative Breast Cancer

Improving Survival for Patients With Stage II Pancreatic Cancer Chemotherapy Followed by Resection

Detection of Emphysema Among Patients With or Without Prior COPD Diagnosis Undergoing Low-Dose CT Screening for Lung Cancer